ByTrending Posts
How Stryker’s Acquisition of care.ai Strengthens Its Push…
Stryker to acquire care.ai to elevate virtual care workflows and expand its healthcare IT leadership Portage, Michigan –…
AI-Powered Clinical Trials: How Unlearn AI, AbbVie, and…
July 30, 2024 Artificial intelligence (AI) is revolutionizing clinical trials, offering greater efficiency and precision. At the Alzheimer’s…
CytoReason Raises $80M from OurCrowd, NVIDIA, Pfizer &…
New funding will scale CytoReason’s AI platform, expand disease models, and support a new office in Cambridge, MA.…
GSK Partners with Ochre Bio in $37.5 Million…
London, UK – June 12 2024 GSK has entered into a $37.5 million strategic partnership with Ochre Bio…
Sanofi, Formation Bio, and OpenAI Forge Strategic Alliance…
Paris, New York, N.Y., and San Francisco, CA — May 21, 2024 Sanofi, Formation Bio, and OpenAI have…
Recursion Unveils BioHive-2: The World’s Largest AI Supercomputer…
Salt Lake City – May 13, 2024 Recursion Pharmaceuticals, a leading clinical-stage TechBio company, has announced the completion…
How Unlearn AI and APST Research Are Revolutionizing…
December 11, 2024 Enhancing Phase II and III Trials by Increasing Statistical Power and Reducing Sample Sizes Unlearn,…
Can BigHat and Johnson & Johnson’s AI-Driven Antibody…
Key Takeaways A Strategic Leap: BigHat Joins Forces with Johnson & Johnson for Neuroscience InnovationBigHat Biosciences, known for…
Endoscopic AI: How Are Medtronic & Cosmo Pharmaceuticals…
Dublin, Ireland – April 12, 2024 — Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) and Medtronic plc (NYSE:…
Trending Posts
Latest Stories
What Lessons from Sanofi’s 2025 Execution Signal Its Future in Oncology, Immunology, and Vaccines?
Sanofi concluded 2025 with a combination of solid portfolio performance, strategic execution, and continued innovation…
How Did Roche’s 2025 Deals Shape Its Strategy and Future Outlook?
In 2025, Roche executed a series of focused deals and collaborations designed to strengthen its…
How Did Roche Navigate 2025 and What Lies Ahead for 2026?
Roche concluded 2025 as a company demonstrating resilient performance, strategic focus, and continued innovation across…
How Did Johnson & Johnson’s 2025 Deals Shape Its Strategy, and What Do They Signal for 2026?
New Brunswick, NJ — In 2025, Johnson & Johnson executed a series of strategic collaborations,…
Gallery
